+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Human Papillomavirus Associated Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Human Papillomavirus Associated Diseases - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Epidermolysis Bullosa - Pipeline Insight, 2025 - Product Thumbnail Image

Epidermolysis Bullosa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Chlamydia Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Chlamydia Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dyspepsia- Pipeline Insight, 2025 - Product Thumbnail Image

Dyspepsia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bone Metastases - Pipeline Insight, 2025 - Product Thumbnail Image

Bone Metastases - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Diphtheria - Pipeline Insight, 2025 - Product Thumbnail Image

Diphtheria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Turner Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Turner Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin 1 Beta Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin 1 Beta Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Placenta Growth Factor Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Placenta Growth Factor Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Complement C5 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C5 Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Serotonin 1B Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Serotonin 1B Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Histamine H1 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Histamine H1 Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Epidermal Growth Factor Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Epidermal Growth Factor Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
T Type Calcium Channel Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

T Type Calcium Channel Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lipodystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Lipodystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Serotonin 3 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Serotonin 3 Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Opioid Kappa Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Kappa Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Amyloid Beta-protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Amyloid Beta-protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Tendinitis - Pipeline Insight, 2025 - Product Thumbnail Image

Tendinitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Vertigo - Pipeline Insight, 2025 - Product Thumbnail Image

Vertigo - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more